Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Trzepacz PT, Cummings J, Konechnik T, Forrester TD, Chang C, Dennehy EB, Willis BA, Shuler C, Tabas LB, Lyketsos C.

Int Psychogeriatr. 2013 May;25(5):707-19. doi: 10.1017/S1041610212002141. Epub 2012 Dec 21.

PMID:
23257314
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.

Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.

Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.

PMID:
23472619
[PubMed - indexed for MEDLINE]
3.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
[PubMed - indexed for MEDLINE]
4.

Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies.

Ballard C, Francis P, Corbett A.

Int Psychogeriatr. 2013 May;25(5):687-9. doi: 10.1017/S1041610213000033. Epub 2013 Jan 25. No abstract available.

PMID:
23347752
[PubMed - indexed for MEDLINE]
5.

AMPA potentiator treatment of cognitive deficits in Alzheimer disease.

Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling R.

Neurology. 2007 Mar 27;68(13):1008-12.

PMID:
17389305
[PubMed - indexed for MEDLINE]
6.

Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.

Sommer OH, Aga O, Cvancarova M, Olsen IC, Selbaek G, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(2):155-63. doi: 10.1159/000199236. Epub 2009 Feb 2.

PMID:
19182483
[PubMed - indexed for MEDLINE]
7.

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.

PMID:
24549548
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.

Herrmann N, Lanctôt KL, Rothenburg LS, Eryavec G.

Dement Geriatr Cogn Disord. 2007;23(2):116-9. Epub 2006 Dec 4.

PMID:
17148938
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
10.

Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study.

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.

CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.

PMID:
21476613
[PubMed - indexed for MEDLINE]
11.

Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH, Raskind MA, Peskind ER.

Am J Geriatr Psychiatry. 2009 Sep;17(9):744-51. doi: 10.1097/JGP.0b013e3181ab8c61.

PMID:
19700947
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

Wilcock GK, Ballard CG, Cooper JA, Loft H.

J Clin Psychiatry. 2008 Mar;69(3):341-8.

PMID:
18294023
[PubMed - indexed for MEDLINE]
13.

Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.

Clin Neurol Neurosurg. 2005 Oct;107(6):497-508.

PMID:
15922506
[PubMed - indexed for MEDLINE]
14.

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.

PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.

PMID:
22567095
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, Schwarz AJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S95-S104.e1. doi: 10.1016/j.jalz.2012.10.005. Epub 2012 Dec 17.

PMID:
23253778
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

Cummings JL, Schneider E, Tariot PN, Graham SM; Memantine MEM-MD-02 Study Group.

Neurology. 2006 Jul 11;67(1):57-63.

PMID:
16832078
[PubMed - indexed for MEDLINE]
17.

Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study.

Peskind ER, Tsuang DW, Bonner LT, Pascualy M, Riekse RG, Snowden MB, Thomas R, Raskind MA.

Alzheimer Dis Assoc Disord. 2005 Jan-Mar;19(1):23-8.

PMID:
15764868
[PubMed - indexed for MEDLINE]
18.

Donepezil for the treatment of agitation in Alzheimer's disease.

Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group.

N Engl J Med. 2007 Oct 4;357(14):1382-92.

PMID:
17914039
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG, Rosenheck RA, Hsiao JK, Lieberman JA, Schneider LS; CATIE-AD Study Group.

Am J Psychiatry. 2008 Jul;165(7):844-54. doi: 10.1176/appi.ajp.2008.07111779. Epub 2008 Jun 2.

PMID:
18519523
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A.

Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31.

PMID:
17974864
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk